Changes in Study Status and Arms and Interventions With Illuminate-301 ... | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1448 of 1471  at  6/18/2019 9:50:24 AM  by

auh2oman


 In response to msg 1447 by  raferjack
view thread

Re: Changes in Study Status and Arms and Interventions With Illuminate-301 ...

Possibly, but I'm leaning towards the logistic reason. It looks like they are synchronizing the four 90 minute Ipilimumab intravenous dosages with four of the nine intratumoral tilsotolimod injections. Much easier for the patients not having to come back the following week for them as they previously had to do.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 152
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
1449 Re: Changes in Study Status and Arms and Interventions With Illuminate-301 ... raferjack 0 6/18/2019 10:00:32 AM


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...